Walgreens Boots Alliance reported fiscal second-quarter revenue that beat analyst expectations, but posted a steep net loss from billions of dollars in impairment charges. The retailer adjusted ...
, opens new tab recorded a $5.8 billion impairment charge on its investment in clinic operator VillageMD on Thursday, hit by a cost-cutting drive to shut down unprofitable sites. VillageMD, a core ...
Walgreens confirmed Tuesday a new round of layoffs, the latest in a string of job cuts over the past year as the retail ...
Walgreens Boots Alliance Inc’s (NASDAQ: WBA) second quarter fiscal year 2024 sales increased 6.3% Y/Y to $37.1 billion, up 5.7% on a constant currency basis, beating the consensus of $35.86 billion.
Walgreens announced last week that it would close 160 of its VillageMD clinics after it recorded a nearly $6 billion non-cash impairment charge in the second quarter, the company said. According ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates a new pharmacy equipped to handle gene and cell therapies with its existing pharmacy assets including ...
One of the more natural evolutions of modern retail in the 21st century has been the convergence of goods and services into a handful of the biggest giants in the industry. While it's long been ...
Walgreens said it will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services. As the ...
Walgreens Boots Alliance is now offering gene and cell therapy services alongside other changes to its specialty pharmacy business as it seeks to find efficiencies and boost revenues. Deerfield ...